{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:02:49Z","timestamp":1758844969767,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.urology.2009.12.083","type":"journal-article","created":{"date-parts":[[2010,6,11]],"date-time":"2010-06-11T06:24:17Z","timestamp":1276237457000},"page":"436-441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Reduction of Prostate-specific Antigen After Tamsulosin Treatment in Patients With Elevated Prostate-specific Antigen and Lower Urinary Tract Symptoms Associated With Low Incidence of Prostate Cancer at Biopsy"],"prefix":"10.1016","volume":"76","author":[{"given":"Andrea","family":"Tubaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cosimo","family":"De Nunzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Trucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Miano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Vicentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucio","family":"Miano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2009.12.083_bib1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0022-5347(17)37401-3","article-title":"Screening for prostatic carcinoma with prostate specific antigen","volume":"147","author":"Brawer","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.12.083_bib2","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.1993.03510080052031","article-title":"Detection of organ confined prostate cancer is increased through prostate-specific antigen-based screening","volume":"270","author":"Catalona","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.urology.2009.12.083_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.eururo.2007.09.002","article-title":"EAU guidelines on prostate cancer","volume":"53","author":"Heidenreich","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2009.12.083_bib4","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.ju.0000078083.38675.79","article-title":"AUA guideline on management of benign prostatic hyperplasia","volume":"170","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.12.083_bib5","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1464-410X.2005.05299.x","article-title":"Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia","volume":"95","author":"Lucas","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2009.12.083_bib6","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0022-5347(01)68067-4","article-title":"Alpha-adrenergic blockade in children with neuropathic and nonneuropathic voiding dysfunction","volume":"162","author":"Austin","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.12.083_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0022-5347(05)00041-8","article-title":"Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater","volume":"175","author":"Kaplan","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.12.083_bib8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0090-4295(97)00302-6","article-title":"Serial prostate-specific antigen measurements in men with clinically benign prostatic hyperplasia during a 12-month placebo-controlled study with terazosin","volume":"50","author":"Roehrborn","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.urology.2009.12.083_bib9","first-page":"155","article-title":"The first prostate-selective alpha 1A-adrenoceptor antagonist: a meta-analysis of two randomized, placebo-controlled, multicentre studies in patients with benign prostatic obstruction (symptomatic BPH)","volume":"29","author":"Chapple","year":"1996","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2009.12.083_bib10","first-page":"597","article-title":"Quinazoline derived \u03b11-adrenoceptor antagonists induce prostate cancer cell apoptosis via an \u03b11-adrenoceptor-independent action","volume":"62","author":"Benning","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2009.12.083_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000083550","article-title":"A local anesthesia reduces pain associated with transrectal prostatic biopsy: a prospective randomized study","volume":"74","author":"Trucchi","year":"2005","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2009.12.083_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0022-5347(01)67064-2","article-title":"Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels","volume":"154","author":"Nadler","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.12.083_bib13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1464-410x.1999.00164.x","article-title":"Prostatic involvement in men with febrile urinary tract infections measured by serum specific antigen and transrectal ultrasound","volume":"84","author":"Ulleryd","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2009.12.083_bib14","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0022-5347(01)64957-7","article-title":"Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value","volume":"157","author":"Irani","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.12.083_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/pros.2990250206","article-title":"Relationship between serum PSA and histological prostatitis in patients with benign prostate hyperplasia","volume":"25","author":"Hasui","year":"1994","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2009.12.083_bib16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000020161","article-title":"Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density","volume":"37","author":"Schatteman","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2009.12.083_bib17","first-page":"549","article-title":"Does asymptomatic inflammation increase PSA?","volume":"36","author":"Gumus","year":"2004","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2009.12.083_bib18","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1159\/000020190","article-title":"Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen","volume":"37","author":"Morote","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2009.12.083_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000051003","article-title":"Diagnostic accuracy of percent free prostate-specific antigen in prostatic pathology and its usefulness in monitoring prostatic cancer patients","volume":"67","author":"Minardi","year":"2001","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2009.12.083_bib20","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.eururo.2004.08.003","article-title":"Effect of NIH-IV prostatitis on free and free-to-total PSA","volume":"46","author":"Stancik","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2009.12.083_bib21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1159\/000020057","article-title":"Percentage of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia","volume":"36","author":"Scattoni","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2009.12.083_bib22","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0022-5347(05)65186-5","article-title":"Treatment of chronic prostatitis lowers serum prostate specific antigen","volume":"16","author":"Bozeman","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.12.083_bib23","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1159\/000052500","article-title":"Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng\/ml and non suspicious results of digital rectal examination","volume":"39","author":"Karazanashvili","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2009.12.083_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.pcan.4500885","article-title":"Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA level between 4 and 10 ng\/ml","volume":"9","author":"Kaygisiz","year":"2006","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urology.2009.12.083_bib25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000089730","article-title":"Can the effect of antibiotherapy and anti-inflammatory therapy on serum PSA level discriminate between benign and malign prostatic pathologies?","volume":"76","author":"Erol","year":"2006","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2009.12.083_bib26","first-page":"23","article-title":"The effect of antibiotics on elevated serum prostate specific antigen in patients with urinary symptoms and negative digital rectal examination: a pilot study","volume":"50","author":"Babul","year":"2002","journal-title":"J Med Liban"},{"key":"10.1016\/j.urology.2009.12.083_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1097-0045(2000)45:9+<42::AID-PROS9>3.0.CO;2-U","article-title":"Effects of \u03b11-adrenoceptor antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease","volume":"9","author":"Kyprianou","year":"2000","journal-title":"Prostate Suppl"},{"key":"10.1016\/j.urology.2009.12.083_bib28","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1097\/01.ju.0000033280.29453.72","article-title":"Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance","volume":"169","author":"Kyprianou","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2009.12.083_bib29","first-page":"29","article-title":"Tamsulosin: the United States trials","volume":"53","author":"Narayan","year":"1998","journal-title":"Geriatrics"},{"key":"10.1016\/j.urology.2009.12.083_bib30","first-page":"187","volume":"55","author":"Hanai","year":"2009","journal-title":"Hinyokika Kiyo"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429510004000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429510004000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:55:02Z","timestamp":1758765302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429510004000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0090429510004000"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2009.12.083","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of Prostate-specific Antigen After Tamsulosin Treatment in Patients With Elevated Prostate-specific Antigen and Lower Urinary Tract Symptoms Associated With Low Incidence of Prostate Cancer at Biopsy","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2009.12.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}